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ABSTRACT
Background: Fructose ingestion with a high-fat beverage increases postprandial lipemia when compared with glucose.
It is unknown whether other sugars, such as galactose, also increase postprandial lipemia.
Objectives: The objective was to assess whether galactose ingestion within a high-fat beverage increases postprandial
lipemia relative to glucose or fructose.
Methods: Two experiments were conducted, which contrasted different test drinks under otherwise standardized
conditions. In Experiment 1, 10 nonobese men (age: 22 ± 1 y; BMI, 23.5 ± 2.2 kg/2) ingested either galactose or
glucose (0.75 g supplemented carbohydrate per·kilogram body mass) within a high-fat test drink (0.94 g fat per kilogram
body mass). In Experiment 2, a separate group of 9 nonobese men (age: 26 ± 6 y; BMI: 23.5 ± 2.6 kg/m2) ingested
either galactose or fructose (identical doses as those in Experiment 1) within the same high-fat test drink. Capillary blood
was sampled before and at frequent intervals after ingestion of the test drinks for a 300-min period to determine plasma
triacylglycerol, glucose, lactate, nonesterified fatty acid, and insulin concentrations. Paired t tests and 2-way, repeated-
measures ANOVA were used to compare conditions within each experiment.
Results: The incremental AUC for triacylglycerol was greater following galactose ingestion compared with glucose
(127 ± 59 compared with 80 ± 48 mmol·L−1 × 300 min, respectively; P = 0.04) but not compared with fructose
(136 ± 74 compared with 133 ± 63 mmol·L−1 ×300 min, respectively; P = 0.91). Plasma lactate concentrations also
increased to a greater extent with galactose compared with glucose ingestion (time–condition interaction: P < 0.001)
but not fructose ingestion (time–condition interaction: P = 0.17).
Conclusions: Galactose ingestion within a high-fat beverage exacerbates postprandial lipemia and plasma lactate
concentrations compared with glucose but not fructose in nonobese men. These data suggest that galactose
metabolism may be more similar to fructose than to glucose, providing a rationale to reassess the metabolic fate of
galactose ingestion in humans. This trial was registered at clinicaltrials.gov as NCT03439878. J Nutr 2020;00:1–8.
Keywords: sugar, metabolism, lipids, fat metabolism, triacylglycerols
Introduction
Plasma triacylglycerol concentrations (lipemia) are a primary
risk factor for cardiovascular disease (CVD), with Mendelian
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randomization supporting a causal role of plasma triacylglyc-
erol concentrations in coronary artery disease (1). Postprandial
triacylglycerol concentrations are thought to provide a better
representation of metabolic health than fasting triacylglycerol
concentrations for at least 2 reasons (2): 1) The fed state
captures the total amount of atherogenic triacylglycerol-rich
lipoproteins in plasma (from both hepatic and intestinal
origin) and 2) the postprandial state predominates most of
the 24-h cycle for the majority of populations in developed
countries (3). Postprandial, as opposed to fasting, triacylglycerol
concentrations therefore better reflect habitual exposure to
atherogenic lipoproteins directly involved in CVD. As such,
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individuals with nonfasting triacylglycerol concentrations >3.5
mmol·L−1 (sampled between 1 and 8 h after a meal)
have a >3-fold increased CVD mortality compared with
those displaying triacylglycerol concentrations <1 mmol·L−1
(2, 4).
Primary nutritional factors that acutely modulate postpran-
dial lipemia include the type and amount of fat in a meal
and the type and amount of carbohydrate that is coingested.
Ultimately, plasma triacylglycerol concentrations reflect the
rate of triacylglycerol appearance (primarily from hepatically
derived VLDL triacylglycerol and intestinally derived chylomi-
cron triacylglycerols) relative to the rate of triacylglycerol
disappearance [primarily into adipose tissue and skeletal muscle
via lipoprotein lipase (LPL) action]. The type of carbohydrate
ingested can further modulate postprandial lipemia via most
of these pathways. For example, fructose ingestion stimulates
hepatic de novo lipogenesis (potentially via lactate production
as a precursor) and glycogen synthesis while suppressing fatty
acid oxidation compared with glucose ingestion (5, 6), which
would result in greater net hepatic triacylglycerol synthesis
and VLDL production (7). In addition, fructose produces a
lower insulin response than glucose (5). In healthy individuals,
acute increases in insulinemia suppress lipolysis and stimulate
LPL activity in adipose tissue (8) while directly suppressing
VLDL secretion by the liver (9). Accordingly, the lower insulin
response to fructose ingestion is also likely to be a major
mechanism explaining the increase in postprandial lipemia via
less suppression of hepatic VLDL secretion (9), less adipose
clearance of triacylglycerols due to lower LPL activity (10),
and higher hepatic nonesterified fatty acid (NEFA) availability
[which contributes to VLDL production (9)].
Galactose is the distinctive monosaccharide of the milk
sugar, lactose (a glucose–galactose disaccharide). Interestingly,
some key metabolic responses to galactose ingestion appear to
mirror those of fructose ingestion, which may be important for
the regulation of postprandial lipemia. For example, galactose
ingestion results in lower plasma glucose and insulin responses
than glucose (11), and galactose ingestion potently stimulates
hepatic glycogen synthesis (12, 13). This raises the possibility
that galactose metabolism is more similar to fructose than
to glucose and may therefore exaggerate postprandial lipemia
compared with glucose ingestion, via a reduction in insulinemia
and/or direct changes in hepatic metabolism. The only ran-
domized, controlled study in humans to measure triacylglycerol
responses to galactose supplementation showed that fasting
triacylglycerol concentrations were increased by ∼30% with
4 d of galactose compared with glucose supplementation (14).
However, to date, no study has assessed the acute postprandial
triacylglycerol responses to galactose ingestion compared with
glucose or fructose.
To this end, the aim of this study was to assess the
acute effect of galactose on postprandial lipemia compared
with glucose (Experiment 1) and fructose (Experiment 2). We
hypothesized that galactose ingestion would increase plasma
triacylglycerol concentrations compared with glucose but not
fructose ingestion.
Methods
This study comprised 2 experiments, each conducted with identical
outcome measures and inclusion/exclusion criteria. Experiment 1
compared galactose with glucose, and Experiment 2 compared galactose
with fructose.
TABLE 1 Participant characteristics
Experiment 1
(n= 10)
Experiment 2
(n= 9)
Age, y 22 ± 1 26 ± 6
Stature, cm 180 ± 6 181 ± 7
Body mass, kg 76 ± 5 78 ± 14
BMI, kg/m2 23.5 ± 2.2 23.5 ± 2.6
Data are means ± SDs.
Experimental design
Both experiments were conducted as single-blind (participant-blinded),
randomized crossover trials, each with 2 arms. Following written,
informed consent, participants visited the laboratories on 2 occasions,
each with a washout period of 7–28 d. Experiment 1 was conducted
at the University of Bath, and Experiment 2 was conducted at Leeds
Beckett University. The experiments were conducted with different
groups of participants, but the participants were recruited with identical
inclusion/exclusion criteria. Once participants were recruited to each
separate experiment, they were randomly assigned to a treatment
sequence. The study protocols were approved by the University of
Bath Research Ethics Approval Committee for Health and the Leeds
Beckett Research Ethics Committee for Experiment 1 and Experiment
2, respectively. All procedures were carried out in accordance with the
Declaration of Helsinki.
Participants
For both experiments, the aim was to recruit 10 nonobese [BMI
(in kg/m2) <30], healthy men from the local area. Inclusion criteria
included age 18–35 y, no history of metabolic disease, and free from
allergies of milk and cream. For Experiment 2, 1 participant was
excluded following completion data analysis after it became clear that
his BMI was >30, which was the prespecified inclusion criteria (BMI
of this individual was 32). Importantly, the inclusion/exclusion of this
participant does not affect any of the statistical interpretations of any
of the outcome measures (data not shown). Accordingly, n = 10 for
Experiment 1 and n = 9 for Experiment 2. Participant characteristics
are reported in Table 1.
Trial days
For 48 h prior to each laboratory trial day, participants standardized
their diet and physical activity and refrained from alcohol consumption
and smoking. Participants also avoided caffeine for 24 h prior to trials
and arrived at the laboratory between 08:30 and 08:45 in an overnight-
fasted state (12-h fast). Water consumption was permitted ad libitum,
recorded on first condition, and replicated on the second condition.
Upon arrival at the laboratory, body mass was determined to the
nearest 0.1 kg (424 Sliding Beam Column scale; Weylux) after voiding;
participants wore only light clothing. Height was measured to the
nearest 0.1 cm using a stadiometer (Seca). A baseline capillary blood
sample was then taken within 15 min prior to ingestion of the test drink.
Participants consumed the test drink within 5 min. A stop clock was
started upon ingestion of the first mouthful, with further capillary blood
samples taken at 30, 60, 90, 120, 180, 240, and 300 min to determine
plasma metabolite and insulin responses to the test drinks.
Test drink composition
The test drinks provided 0.94 g fat per kilogram body mass and
0.75 g supplemental carbohydrate per kilogram body mass. They were
composed of cream and whole-fat milk, supplemented with galactose
(Galaxtra; Solace Nutrition), dextrose (Myprotein), or fructose (Hol-
land & Barrett), all flavored with 0.5 mL of chocolate/vanilla flavor
droplets (Myprotein Flavdrops). The composition of test meals is given
in Table 2. The rationale for the dose of fat was to produce a robust
triacylglyceridemic response (15), and that for the dose of carbohydrate
was to broadly replicate prior work on fructose ingestion (5). We
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TABLE 2 Test drink composition
Experiment 1 (n= 10) Experiment 2 (n= 9)
Glucose Galactose Fructose Galactose
Energy, kcal·kg−1 13 13 13 13
Fat, g·kg−1 0.94 0.94 0.94 0.94
Lactose, g·kg−1 0.17 0.17 0.17 0.17
Glucose, g·kg−1 0.75 0 0 0
Galactose, g·kg−1 0 0.75 0 0.75
Fructose, g·kg−1 0 0 0.75 0
Protein, g·kg−1 0.12 0.12 0.12 0.12
normalized the doses to body mass in an attempt to standardize the
relative nutrient exposure across participants.
Blood sampling and analyses
To stimulate peripheral blood flow, participants placed their hand
in a bowl of warm (∼40◦C) water 5 min prior to each capillary
blood sample. Blood samples were collected via finger prick (Lancets
Accu-Check Safe T Pro Plus; Roche Diabetes Care) in a 300-
μL microvette capillary tube (Microvette CB 300 K2E; Sarstedt).
Capillary sampling is preferable to venous sampling for postprandial
concentrations of glucose and insulin because peripheral tissues extract
glucose and lactate to a variable extent in the postprandial state.
This leads to lower concentrations in venous blood compared with
arterial/arterialized blood; due to the variable nature of this reduction,
simple correction factors are not possible (16, 17). Capillary blood has
been shown to be representative of arterialized blood under a variety of
metabolic conditions (16) and therefore is preferable to venous blood
sampling for determining the peripheral exposure to metabolites and
hormones.
The collected capillary samples were centrifuged (Hareus Biofuge
Pico; DJB Labcare) at 9503 × g for 10 min at room temperature. The
extracted plasma samples were aliquoted into 0.5-mL tubes (model
5810; Eppendorf) and stored in a freezer at−80◦C before later analysis.
Plasma triacylglycerol and NEFA concentrations were measured in
duplicate and were assayed using enzymatic colorimetric techniques
(Wako Pure Chemical Industries). Interplate CVs were <8.7% and
<5.9% for triacylglycerol and NEFA, respectively. Plasma insulin
concentrations were analyzed in singular using a solid-phase 2-site
enzyme immunoassay (Mercodia Insulin ELISA; Mercodia). Plasma
glucose and l-lactate concentrations were analyzed in singular using an
automated analyzer (YSI 2300 Stat Plus; YSI). Due to a lack of sufficient
sample for 1 participant, plasma lactate concentrations are n = 9 for
both experiments.
Calculations and statistical analyses
The primary outcome for the current study was the incremental
AUC (iAUC) for plasma triacylglycerol concentrations. Plasma glucose,
insulin, NEFA, and lactate concentrations were secondary outcome
measures. The sample size was based on prior work comparing fructose
with starch (as a glucose-based carbohydrate) ingestion within a
high-fat beverage on postprandial triacylglycerol concentrations (18).
The time-averaged iAUC for triacylglycerol concentrations following
fructose ingestion was 609 ± 203 μmol·L−1 compared with 379 ± 191
μmol·L−1 following starch ingestion. Based on this effect size (d= 1.17),
10 participants should provide >90% power to detect an effect of a
similar magnitude with an α level of 0.05 when using a 2-tailed, paired
t test. Data are presented as means ± SDs, unless otherwise stated.
The variance bars on figures are presented as means with 95% CIs.
Incremental AUC was calculated for triacylglycerol, glucose, insulin,
and lactate concentrations using the trapezoid method, ignoring values
less than the baseline (19). The total AUC was calculated for NEFA
concentrations because these were suppressed below baseline following
ingestion of the test drink. Paired differences were checked for normal
distribution by the Shapiro–Wilk normality test prior to analysis (with
P ≤ 0.05 being accepted as significant). Based on these analyses, all data
were deemed not to deviate significantly from a normal distribution.
Paired t tests were employed to assess differences between non-time-
dependent variables, whereas differences between conditions in time-
dependent variables (plasma triacylglycerol, insulin,NEFA, glucose, and
lactate concentrations) were analyzed using a 2-way repeated-measures
ANOVA (condition–time). A 2-tailed P value of ≤0.05 was considered
statistically significant. The magnitude of difference between conditions
was also expressed via Cohen’s d effect size and is presented where
small (d = 0.2–0.5), moderate (d = 0.5–0.8), or large (d > 0.8) effects
were observed. Out of a possible total of 3040 data points, 18 data
points (0.59%) were missing due to a lack of sufficient plasma sample
for analysis. When this was the case, the means of samples on each
side of this time point were taken (e.g., for a missing 30-min sample,
the means of 15-min and 45-min samples were used). Results were
analyzed using Microsoft Excel version 15.26 and GraphPad Prism
version 8.0.2.
Results
Plasma triacylglycerol concentrations
In Experiment 1, no differences were detected in fasting plasma
triacylglycerol concentrations between conditions (Table 3).
Following ingestion of the test drinks, plasma triacylglycerol
concentrations increased during the postprandial period in both
conditions (time effect, P < 0.001). The increase in plasma
triacylglycerol concentrations was greater following galactose
compared with glucose ingestion (P-interaction = 0.002;
Figure 1A). The plasma triacylglycerol iAUC was ∼60%
greater with galactose compared with glucose ingestion with a
moderate to large effect size (P = 0.04; Figure 1C; d = 0.75).
In Experiment 2, no differences were detected in fast-
ing plasma triacylglycerol concentrations between conditions
(Table 3). Following ingestion of the test drinks, plasma
triacylglycerol concentrations increased during the postprandial
period in both conditions (time effect, P < 0.001) but
did not differ between galactose and fructose ingestion (P-
interaction = 0.81; Figure 1B). There was no difference in the
plasma triacylglycerol iAUC between galactose and fructose
ingestion, and there was a negligible effect size (P = 0.91;
Figure 1D; d = 0.04).
Plasma glucose and insulin concentrations
In Experiment 1, no differences were detected in fasting
plasma glucose or insulin concentrations between conditions
(Table 3). Following ingestion of the test drinks, plasma glucose
concentrations initially increased (time effect, P < 0.001) to
a peak at 45 ± 29 and 39 ± 14 min following glucose
and galactose ingestion, respectively (P = 0.62). The increase
in plasma glucose concentrations was smaller with galactose
than with glucose ingestion (P-interaction < 0.001; Figure 2A,
Table 4). Similarly, plasma insulin concentrations initially
increased (time effect, P < 0.001) to a peak at 45 ± 16
and 51 ± 32 min following glucose and galactose ingestion,
respectively (P = 0.51). The increase in plasma insulin
concentrations was smaller with galactose than with glucose
ingestion (P-interaction < 0.001; Figure 2C).
In Experiment 2, no differences were detected in fasting
plasma glucose or insulin concentrations between conditions
(Table 3). Following ingestion of the test drinks, plasma glucose
initially increased (time effect, P < 0.001) to a peak at 37 ± 20
and 57 ± 51 min following fructose and galactose ingestion,
respectively (P = 0.30). Plasma glucose concentrations did not
differ following galactose compared with fructose ingestion
(P-interaction = 0.72; Figure 2B, Table 4). Similarly, plasma
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TABLE 3 Fasting plasma triacylglycerol, glucose, insulin, NEFA, and lactate concentrations in healthy, nonobese men prior to
ingestion of a high-fat beverage containing glucose, galactose, or fructose in 2 separate experiments
Experiment 1 (n= 10) Experiment 2 (n= 9)
Glucose Galactose P Fructose Galactose P
Plasma triacylglycerol concentration, mmol·L−1 0.99 ± 0.14 0.90 ± 0.33 0.270 0.96 ± 0.29 0.86 ± 0.26 0.408
Plasma glucose concentration, mmol·L−1 5.06 ± 0.25 5.06 ± 0.38 0.984 5.25 ± 0.22 5.34 ± 0.30 0.402
Plasma insulin concentration, mmol·L−1 32 ± 13 31 ± 12 0.749 38 ± 18 38 ± 12 0.904
Plasma NEFA concentration, mmol·L−1 0.40 ± 0.14 0.38 ± 0.11 0.618 0.29 ± 0.07 0.35 ± 0.10 0.209
Plasma lactate concentration, mmol·L−1 0.92 ± 0.17 0.89 ± 0.21 0.713 1.35 ± 0.49 1.41 ± 0.46 0.646
Data are means ± SDs. P values represent 2-tailed, paired t tests. NEFA, nonesterified fatty acid.
insulin concentrations initially increased (time effect,P< 0.001)
to a peak at 50 ± 34 and 130 ± 89 min following
fructose and galactose ingestion, respectively (P = 0.032), and
plasma insulin concentrations did not differ following galactose
compared with fructose ingestion (P-interaction = 0.68;
Figure 2D).
Plasma NEFA and lactate concentrations
In Experiment 1, no differences were detected in fasting
plasma NEFA or lactate concentrations between conditions
(Table 3). Following ingestion of the test drinks, plasma
NEFA concentrations declined during the initial postprandial
period in both conditions (time effect, P < 0.001). The
decline in plasma NEFA concentrations did not differ between
galactose and glucose (P-interaction = 0.59; Figure 3A,
Table 4). Plasma lactate concentrations initially increased in
both conditions (time effect, P < 0.001). The increase in plasma
lactate concentrations was ∼4-fold greater with galactose than
with glucose ingestion (P-interaction < 0.001; Figure 3C,
Table 4).
In Experiment 2, no differences were detected in fasting
plasma NEFA or lactate concentrations between conditions
(Table 3). Following ingestion of the test drinks, plasma NEFA
concentrations declined during the initial postprandial period
in both conditions (time effect, P < 0.001). The decline in
plasma NEFA concentrations did not differ between galactose
and fructose ingestion (P-interaction = 0.12; Figure 3B,
Table 4). Plasma lactate concentrations initially increased in
both conditions (time effect, P < 0.001) and did not differ
following galactose or fructose ingestion (P-interaction = 0.17;
Figure 3D, Table 4).
FIGURE 1 Plasma triacylglycerol concentrations (A, B) and iAUCs (C, D) in healthy, nonobese men following ingestion of a high-fat beverage
containing galactose compared with glucose (A, C) or fructose (B, D) in 2 separate experiments. Right-hand y axes represent the difference
between conditions (within each experiment) for plasma triacylglycerol iAUC. Data are means ± 95% CIs; n = 10 (A, C) and n = 9 (B, D)
nonobese men. Assessed by 2-way, repeated-measures ANOVA. Paired 2-tailed t tests were used to compare the iAUC between conditions.
iAUC, incremental area under the curve.
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FIGURE 2 Plasma glucose (A, B) and insulin (C, D) concentrations in healthy, nonobese men following ingestion of a high-fat beverage
containing galactose compared with glucose (A, C) or fructose (B, D) in 2 separate experiments. Data are means ± 95% CIs; n = 10 (A, C) and
n = 9 (B, D) nonobese men. Assessed by 2-way, repeated-measures ANOVA.
Discussion
This study is the first to demonstrate that acute ingestion of
a large (∼58 g) dose of galactose within a high-fat beverage
modestly increases postprandial triacylglycerol concentrations
compared with glucose but not fructose. Furthermore, galactose
ingestion resulted in higher plasma lactate but lower glucose
and insulin concentrations compared with glucose but not
fructose ingestion. Collectively, these data suggest that galactose
produces a metabolic milieu that is more similar to fructose
than to glucose ingestion, providing a rationale to reassess the
metabolic consequences of milk sugars in humans.
Themodest increase in plasma triacylglycerol concentrations
seen with ∼58 g of galactose compared with glucose ingestion
could be due to increased triacylglycerol appearance rates
and/or decreased plasma triacylglycerol clearance. Insulin is a
key hormone regulating triacylglycerol metabolism in the post-
prandial state. In the current study, insulinemia and glycemia
during the first 90 min of the postprandial state following
galactose ingestion was less than half that seen following
glucose ingestion. On the other hand, both insulinemia and
glycemia displayed comparable responses following galactose
versus fructose ingestion. These data are therefore consistent
with the idea that the lower plasma glucose concentrations
following galactose compared with glucose ingestion stimulated
a lower insulinemic response, and that in turn could partly
explain the elevated triacylglycerol concentrations.
Lower plasma insulin concentrations could lead to higher
triacylglycerol concentrations via a number of mechanisms,
including lesser suppression of adipose tissue lipolysis and thus
greater hepatic NEFA availability (used for VLDL triacylglyc-
erol production), less direct suppression of VLDL triacylglycerol
secretion, and less triacylglycerol clearance by lower activation
of LPL in adipose tissue. The first of these potential mechanisms
is unlikely to explain the higher triacylglycerol concentrations
observed with galactose compared with glucose ingestion in
the current study. In healthy individuals, insulin concentrations
of ∼34 pmol·L−1 are sufficient to almost completely inhibit
TABLE 4 Postprandial iAUC of glucose, insulin, NEFA, and lactate concentrations in healthy, nonobese men following ingestion of a
high-fat beverage containing glucose, galactose, or fructose in 2 separate experiments
Experiment 1 (n= 10) Experiment 2 (n= 9)
Glucose Galactose P Fructose Galactose P
Glucose iAUC, mmol·L−1 × 300 min 123 ± 51 46 ± 47 0.004 44 ± 64 21 ± 17 0.31
Insulin iAUC, mmol·L−1 × 300 min 21 ± 9 10 ± 4 0.001 6 ± 4 8 ± 6 0.53
NEFA AUC, mmol·L−1 × 300 min 100 ± 21 95 ± 14 0.35 88 ± 23 97 ± 20 0.29
Lactate iAUC, mmol·L−1 × 300 min 51 ± 30 208 ± 35 <0.001 212 ± 93 222 ± 133 0.87
Data are means ± SDs. P values represent 2-tailed, paired t tests. iAUC, incremental AUC; NEFA, nonesterified fatty acid.
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FIGURE 3 Plasma NEFA (A, B) and lactate (C, D) concentrations in healthy, nonobesemen following ingestion of a high-fat beverage containing
galactose compared with glucose (A, C) or fructose (B, D) in 2 separate experiments. Data are means ± 95% CIs; n = 10 (A) and n = 9 (B–D)
nonobese men. Assessed by 2-way, repeated-measures ANOVA. NEFA, nonesterified fatty acid.
whole-body lipolysis (8). Because plasma insulinemia peaked
at >100 pmol·L−1 following ingestion of glucose, galactose, or
fructose, the suppression of adipose tissue lipolysis is likely to
have beenmaximal under all conditions in the current study, and
thus hepatic NEFA availability for VLDL production would not
have been altered by galactose compared with glucose ingestion
(9). Moreover, the higher lactate concentrations with galactose
compared with glucose ingestion could also suppress lipolysis
and thereby offset any reduction in insulinemia on NEFA
appearance (20), although the effects of lactate on adipose
lipolysis in humans are still unclear (21, 22). Nevertheless,
plasma NEFA concentrations in the current study did not
differ following galactose compared with glucose ingestion,
suggesting lipolysis was similarly suppressed in both conditions.
The higher triacylglycerol concentrations with galactose
compared with glucose ingestion could therefore be due to
less direct suppression of VLDL secretion as a result of
lower insulinemia (9). However, there is also evidence that the
difference in insulinemia observed in the current study may
be insufficient to influence postprandial plasma triacylglycerol
concentrations, at least during the initial 180 min of the
postprandial period. For example, isomaltulose is composed of
identical monomers as sucrose. Due to a slow rate of hydrolysis,
isomaltulose ingestion produces lower glycemic and insulinemic
responses than sucrose, likely due to slower substrate fluxes (23,
24). The difference in insulinemia with isomaltulose compared
with sucrose is comparable to the insulin responses observed
in the current study (23), yet no difference in triacylglycerol
concentrations was reported with isomaltulose compared with
sucrose ingestion with a mixed meal (23). This suggests that
the exaggerated triacylglycerol response to galactose ingestion
may not solely be due to differences in insulinemia and could be
explained by other contributory mechanisms.
Further regulators of triacylglycerol metabolism include
hepatic de novo lipogenesis (DNL) and intestinal lipoprotein
production, which each could contribute to higher postprandial
triacylglycerol concentrations. Fructose ingestion is well known
to stimulate hepatic DNL acutely and chronically (7), and
it can also stimulate intestinal production of triacylglycerol-
rich lipoproteins from enterocytes (25). Although the direct
conversion of fructose into fatty acids is not likely to be quan-
titatively important for postprandial lipemia (5), stimulation
of hepatic DNL could be quantitatively important for plasma
triacylglycerol concentrations if there is a greater conversion
of all DNL precursors (e.g., glucose, fructose, and lactate)
into DNL products (fatty acids and glycerol) (7). The acute
increase in DNL with fructose ingestion is thought to be
due to the rapid and relatively unregulated flux of fructose
metabolism in the liver. This leads to an accumulation of
triose phosphate, which can be converted into triacylglycerols,
lactate, and/or glucose and glycogen (7). Therefore, the increase
in lactate concentrations following ingestion of carbohydrates
may be reflective of accumulation of triose phosphate and
could occur in parallel with DNL. Furthermore, the potent
stimulation of glycogen synthesis could also tip the balance of
hepatic fatty acid metabolism toward net lipid synthesis (7).
The classical view of human galactose metabolism is that the
Leloir pathway is the dominant pathway, whereby galactose
is ultimately converted into UDP-glucose, and subsequent
steps then follow similar pathways to glucose metabolism
(26). In the current study, we observed greater increases in
plasma lactate concentrations following galactose compared
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with glucose ingestion and comparable lactate concentrations
following galactose compared with fructose ingestion. Because
the increase in lactate concentrations with fructose ingestion is
thought to be due to the lack of feedback and regulation of
hepatic fructosemetabolism comparedwith glucosemetabolism
(7, 27), the current data suggest that galactose metabolism
may be more similar to fructose than to glucose metabolism.
When interpreted alongside the evidence that fructose and
galactose ingestion both potently stimulate hepatic glycogen
synthesis compared with glucose ingestion (12), this raises
the possibility that glycogen fluxes could be involved in the
postprandial triacylglycerol responses observed in the current
study (7) and questions the accuracy of the classical view of
galactose metabolism in humans. These data therefore provide
a basis for future work to establish the mechanistic effects of
galactose on hepatic lipid metabolism in humans.
The current study was conducted in nonobese men; there is
a need to understand if galactose ingestion alters postprandial
triacylglycerol metabolism in other populations. Given that
sex and obesity can each alter the metabolic responses to
fructose ingestion (18, 28), future work should establish
whether there are sex differences in response to galactose
ingestion and whether obesity status alters this response. Due
to the measurement of triacylglycerol concentrations alone, it
is not possible to establish whether the higher triacylglycerol
concentrations were due to an increase in triacylglycerol-rich
lipoprotein size or particle number. In addition, the potential
mechanisms that may explain the acute increase in postprandial
lipemia require elucidation.A further limitationwith the current
study is that galactose and fructose were provided without
adding glucose to the test drinks. This may have implications
for translation because galactose and fructose are almost always
ingested along with glucose under free-living conditions, which
can alter the metabolism of these sugars (29). The dose of
galactose ingested in the current study was relatively large
(equivalent in sugar content to ∼1.4 L of milk); galactose is
unlikely to be commonly consumed in this dose under free-living
conditions. Nevertheless, if galactose and fructose exaggerate
postprandial lipemia via shared mechanisms, an additive or
synergistic effect of galactose and fructose ingestion is possible.
This would have consequences for food products containing
galactose and fructose in combination, such as sugar-sweetened
milkshakes, yoghurts, and ice cream. Finally, note that the
current study design only permits comparisons within each
experiment and therefore comparisons between experiments are
indirect. This limits the ability to directly assess how galactose
and fructose differ in regard to glucose ingestion with a high-fat
beverage.
In summary, acute ingestion of ∼58 g of galactose with a
high-fat beverage increases postprandial lipemia and plasma
lactate concentrations compared with glucose but not fructose.
These data suggest that galactose metabolism may be more
similar to fructose than to glucose metabolism and thereby
provide a rationale to reassess the metabolic consequences
of galactose ingestion in humans. Furthermore, the similar
metabolic response to galactose and fructose ingestion suggests
that ingestion of these sugars may produce combined effects
on triacylglycerol metabolism, with potential implications for
the ingestion of sugar-sweetened dairy products. However, the
large doses used in the current study are not reflective of typical
dietary intakes; therefore, further studies are needed using more
representative amounts of these sugars to determine their effects
on postprandial responses.
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